GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Valuation Rank

Can B (CANB) Valuation Rank


View and export this data going back to 2011. Start your Free Trial

What is Can B Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Can B Valuation Rank Related Terms

Thank you for viewing the detailed overview of Can B's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Can B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Valuation Rank
Comparable Companies
SBFM HYEX CPHI ABTI CVSI MSTH CLSH LIFD STEK CBIH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
960 South Broadway, Suite 120, Hicksville, NY, USA, 11801
Website
https://www.canbiola.com
Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.
Executives
Mckenzie Webster Ltd 10 percent owner DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple director, officer: CFO, Director, and Secretary 94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer officer: EVP Business Development 65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv director 90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel officer: COO 6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen 10 percent owner 445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi director, 10 percent owner, officer: CEO, Board Member 44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley director 15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760